n(4)-hydroxycytidine has been researched along with Coronavirus Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, ML; Baric, RS; Bluemling, GR; Brown, AJ; Chappell, JD; Denison, MR; Dinnon, KH; George, AS; Graham, RL; Harcourt, J; Hill, CS; Hughes, TM; Kolykhalov, AA; Leist, SR; Lu, X; Montgomery, SA; Natchus, MG; Painter, G; Pruijssers, AJ; Saindane, M; Schäfer, A; Sheahan, TP; Sims, AC; Stevens, LJ; Swanstrom, R; Tamin, A; Thornburg, NJ; Zhou, S | 1 |
| Agostini, ML; Andres, EL; Baric, RS; Bluemling, GR; Chappell, JD; Denison, MR; Gribble, J; Kolykhalov, AA; Lockwood, MA; Lu, X; Natchus, MG; Painter, GR; Pruijssers, AJ; Saindane, M; Sheahan, TP; Sims, AC | 1 |
| Berkhout, B; Bosch, BJ; Dijkman, R; Jebbink, MF; Pyrc, K; Rottier, P; van der Hoek, L | 1 |
3 other study(ies) available for n(4)-hydroxycytidine and Coronavirus Infections
| Article | Year |
|---|---|
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Topics: Adenosine Monophosphate; Alanine; Animals; Antibiotic Prophylaxis; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-19; Cytidine; Disease Models, Animal; Drug Resistance, Viral; Humans; Hydroxylamines; Lung; Mice; Mice, Inbred C57BL; Middle East Respiratory Syndrome Coronavirus; Models, Molecular; Mutation; Pandemics; Pneumonia, Viral; Primary Cell Culture; Random Allocation; Respiratory System; Ribonucleosides; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Virus Replication | 2020 |
Small-Molecule Antiviral β-d-
Topics: Animals; Antiviral Agents; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; Coronaviridae Infections; Coronavirus Infections; Cytidine; Drug Resistance, Viral; Exoribonucleases; Mice; Middle East Respiratory Syndrome Coronavirus; Murine hepatitis virus; Mutagenesis; RNA-Dependent RNA Polymerase; Vero Cells; Viral Nonstructural Proteins; Virus Replication | 2019 |
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
Topics: Animals; Antiviral Agents; Azauridine; Base Sequence; Cell Line; Cell Survival; Coronavirus; Coronavirus Infections; Cytidine; Cytopathogenic Effect, Viral; Humans; Inhibitory Concentration 50; Macaca mulatta; Molecular Structure; Neutralization Tests; Nucleosides; Receptors, Virus; RNA Interference; RNA, Small Interfering; RNA, Viral; Time Factors; Virus Replication | 2006 |